We are live on
!
Find out more
PHS
PFM Health Sciences Portfolio holdings
AUM
$1.1B
1-Year Est. Return
57.92%
This Fund
S&P 500
This Quarter
Est. Return
+8.13%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.81B
AUM Growth
–
Cap. Flow
+$4.76B
Cap. Flow
% of AUM
98.8%
Top 10 Holdings %
Top 10 Hldgs %
46.28%
Holding
74
New
72
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$362M |
| 2 |
Pfizer
PFE
|
+$309M |
| 3 |
Eaton
ETN
|
+$287M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$243M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$210M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.44% |
| 2 | Communication Services | 15.27% |
| 3 | Industrials | 11.82% |
| 4 | Consumer Discretionary | 7.56% |
| 5 | Real Estate | 6.89% |
Similar funds
DAM
MAM
CPRC
AWP
LCM
PRS
DAM
KCM
PFM Health Sciences's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for PFM Health Sciences, which disclosed 74 positions worth $4.81B. Its ten largest holdings account for 46% of the portfolio.
Its largest position is Gilead Sciences: 6,954,488 shares worth $357M.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, followed by Communication Services and Industrials.
- PFM Health Sciences's largest Q2 2013 buy was Gilead Sciences: 6,954,488 shares worth $357M.
- PFM Health Sciences's ten largest holdings make up 46% of its $4.81B portfolio in Q2 2013.
- PFM Health Sciences disclosed 74 positions in Q2 2013, its first 13F filing on record.
Based on PFM Health Sciences's 13F filing for Q2 2013, filed 14 Aug 2013.